Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration
Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology and several other disease areas, through a collaboration that could generate more than...
Case Western Reserve University receives grant to investigate AML treatment for veterans
With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University are investigating a new approach to treat Acute Myeloid Leukemia (AML) in military Veterans....
De novo antibody protein sequencing reveals novel functional and neutralizing antibodies post-SARS-CoV-2 vaccination
Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb® antibody discovery platform was used to sequence a complex mixture of functional antibodies directly from the serum...
Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent...
Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair...
AI model LucaProt uncovers 251,000 new RNA viruses, revealing hidden diversity worldwide
A new deep learning model, LucaProt, has detected over 251,000 new RNA virus species from global ecosystems, revealing unprecedented viral diversity in places like Antarctic sediment and extreme aquatic environments. Discover how this breakthrough...
StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer
It happens in Hollywood and on Broadway: Sometimes a great production wins mostly positive reviews from the critics but fails to wow the audience.
The critics here are analysts, who largely applauded Illumina (ILMN) for...
New computational pipeline revolutionizes personalized cancer vaccine design
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence algorithms to...
Bruker Unveils Spatial Strategy Post NanoString Acquisition
When NanoString Technologies—a pioneering spatial biology company in Seattle—filed for bankruptcy in February this year, the future of the company and its technology remained unknown. Although Joe Beechem, PhD, NanoString’s founding CSO at the...
With $5.3M in Funding, clock.bio Makes Progress on Longevity Research Using Stem Cells
Extending human health span by several years is the vision of clock.bio, a biotech startup that is investigating the biology of cellular rejuvenation. The company recently raised $5.3 million in seed funding in a...
Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology
The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet?
On October 2nd, the FDA cleared an investigational new drug (IND) application for a...
